Literature DB >> 28116923

Effects of prolonged methylprednisolone treatment after pulse therapy for paraquat-intoxicated rats.

S Y Feng1, J Gao1, J Wang1, Y Li1.   

Abstract

OBJECTIVE: This study was designed to evaluate prolonged methylprednisolone (MP) treatment after pulse therapy for paraquat (PQ)-intoxicated rats.
METHOD: Acute PQ toxicity was induced by intraperitoneally injecting single toxic dose of 25 mg/kg of body weight. Rats were divided into four groups: control group (saline solution for 15 days), PQ group (saline solution for 15 days after PQ toxicity), pulse group (15 mg·kg-1·day-1 MP for 3 days after PQ toxicity and then saline solution for 12 days) and pulse + prolonged group (15 mg·kg-1·day-1 MP for 3 days after PQ toxicity; dosage was subsequently reduced by half every 2 days, and MP was terminated until 0.47 mg·kg-1·day-1). Hydroxyproline (HYP) content in lung tissues was evaluated through enzyme-linked immunosorbent assay, and lung fibrosis was examined using a semiquantitative scoring system (Ashcroft staging criteria). Lung wet-to-dry weight (W/Dc) ratio and 15-day survival rates of the rats were also analysed.
RESULTS: Similar survival rates (55.0 vs. 65.0%) were obtained for the pulse group and the pulse + prolonged group. The W/Dc (4.79 ± 0.42 vs. 5.29 ± 0.35), HYP content in the lung tissues (3.23 ± 0.24 vs. 3.72 ± 0.23 μg/mg) and lung fibrosis scores (2.69 ± 0.74 vs. 3.12 ± 0.60) of the pulse + prolonged group were lower than those of the pulse group.
CONCLUSION: Prolonged MP treatment after pulse therapy could effectively ameliorate PQ-intoxicated acute lung injury in rats. However, further studies should be performed to verify our findings.

Entities:  

Keywords:  Paraquat; hydroxyproline; lung fibrosis; methylprednisolone; survival rate

Mesh:

Substances:

Year:  2017        PMID: 28116923     DOI: 10.1177/0960327117689909

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Combined signaling of NF-kappaB and IL-17 contributes to Mesenchymal stem cells-mediated protection for Paraquat-induced acute lung injury.

Authors:  Lichun Zhang; Yu Wang; Haitao Shen; Min Zhao
Journal:  BMC Pulm Med       Date:  2020-07-17       Impact factor: 3.317

2.  Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury.

Authors:  Weiwei Su; Qinglian Dong; Fangfang Jiao
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.